Report Detail

Chemical & Material Global and United States HEPES Solution Market Report & Forecast 2022-2028

  • RnM4421672
  • |
  • 11 April, 2022
  • |
  • Global
  • |
  • 129 Pages
  • |
  • QYResearch
  • |
  • Chemical & Material

Summary:

HEPES (N-(2-Hydroxyethyl)piperazine-N'-2-ethanesulfonic Acid)) Buffers is a zwitterionic organic chemical buffering agent. HEPES Buffers is widely used in cell culture, molecular biology and biochemical researches, largely because it is better at maintaining physiological pH.
Market Analysis and Insights: Global and United States HEPES Solution Market
This report focuses on global and United States HEPES Solution market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global HEPES Solution market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Purity 98% accounting for % of the HEPES Solution global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Cell Culture was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the HEPES Solution market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global HEPES Solution Scope and Market Size
HEPES Solution market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global HEPES Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the HEPES Solution market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the HEPES Solution market is segmented into
Purity 98%
Purity 99%
Purity 99.5%
Segment by Application, the HEPES Solution market is segmented into
Cell Culture
Protein Extraction
Others
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and HEPES Solution Market Share Analysis
HEPES Solution market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in HEPES Solution business, the date to enter into the HEPES Solution market, HEPES Solution product introduction, recent developments, etc.
The major vendors covered:
Avantor
Thermo Fisher
Merck
Lonza
Cytiva
Promega Corporation
MP Biomedicals
Spectrum Laboratory
Biological Industries
Cayman Chemical
SERVA Electrophoresis GmbH
Bio-Techne
BioSpectra
Corning
FUJIFILM Irvine Scientific, Inc.
Dojindo Laboratories
XZL Bio-Technology
Suzhou Yacoo Science
Haihang Chemical
Yunbang Bio-pharmaceutical


Table of Contents

    1 Study Coverage

    • 1.1 HEPES Solution Product Introduction
    • 1.2 Global HEPES Solution Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global HEPES Solution Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global HEPES Solution Sales in Volume for the Year 2017-2028
    • 1.3 United States HEPES Solution Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States HEPES Solution Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States HEPES Solution Sales in Volume for the Year 2017-2028
    • 1.4 HEPES Solution Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States HEPES Solution in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of HEPES Solution Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 HEPES Solution Market Dynamics
      • 1.5.1 HEPES Solution Industry Trends
      • 1.5.2 HEPES Solution Market Drivers
      • 1.5.3 HEPES Solution Market Challenges
      • 1.5.4 HEPES Solution Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 HEPES Solution Market Segment by Type
      • 2.1.1 Purity 98%
      • 2.1.2 Purity 99%
      • 2.1.3 Purity 99.5%
    • 2.2 Global HEPES Solution Market Size by Type
      • 2.2.1 Global HEPES Solution Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global HEPES Solution Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global HEPES Solution Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States HEPES Solution Market Size by Type
      • 2.3.1 United States HEPES Solution Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States HEPES Solution Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States HEPES Solution Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 HEPES Solution Market Segment by Application
      • 3.1.1 Cell Culture
      • 3.1.2 Protein Extraction
      • 3.1.3 Others
    • 3.2 Global HEPES Solution Market Size by Application
      • 3.2.1 Global HEPES Solution Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global HEPES Solution Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global HEPES Solution Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States HEPES Solution Market Size by Application
      • 3.3.1 United States HEPES Solution Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States HEPES Solution Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States HEPES Solution Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global HEPES Solution Competitor Landscape by Company

    • 4.1 Global HEPES Solution Market Size by Company
      • 4.1.1 Top Global HEPES Solution Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global HEPES Solution Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global HEPES Solution Sales by Manufacturer (2017-2022)
      • 4.1.4 Global HEPES Solution Price by Manufacturer (2017-2022)
    • 4.2 Global HEPES Solution Concentration Ratio (CR)
      • 4.2.1 HEPES Solution Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of HEPES Solution in 2021
      • 4.2.3 Global HEPES Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global HEPES Solution Manufacturing Base Distribution, Product Type
      • 4.3.1 Global HEPES Solution Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers HEPES Solution Product Type
      • 4.3.3 Date of International Manufacturers Enter into HEPES Solution Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States HEPES Solution Market Size by Company
      • 4.5.1 Top HEPES Solution Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States HEPES Solution Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States HEPES Solution Sales by Players (2020, 2021 & 2022)

    5 Global HEPES Solution Market Size by Region

    • 5.1 Global HEPES Solution Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global HEPES Solution Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global HEPES Solution Sales in Volume by Region: 2017-2022
      • 5.2.2 Global HEPES Solution Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global HEPES Solution Market Size in Value by Region (2017-2028)
      • 5.3.1 Global HEPES Solution Sales in Value by Region: 2017-2022
      • 5.3.2 Global HEPES Solution Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America HEPES Solution Market Size YoY Growth 2017-2028
      • 6.1.2 North America HEPES Solution Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific HEPES Solution Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific HEPES Solution Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe HEPES Solution Market Size YoY Growth 2017-2028
      • 6.3.2 Europe HEPES Solution Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America HEPES Solution Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America HEPES Solution Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa HEPES Solution Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa HEPES Solution Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Avantor
      • 7.1.1 Avantor Corporation Information
      • 7.1.2 Avantor Description and Business Overview
      • 7.1.3 Avantor HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Avantor HEPES Solution Products Offered
      • 7.1.5 Avantor Recent Development
    • 7.2 Thermo Fisher
      • 7.2.1 Thermo Fisher Corporation Information
      • 7.2.2 Thermo Fisher Description and Business Overview
      • 7.2.3 Thermo Fisher HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 Thermo Fisher HEPES Solution Products Offered
      • 7.2.5 Thermo Fisher Recent Development
    • 7.3 Merck
      • 7.3.1 Merck Corporation Information
      • 7.3.2 Merck Description and Business Overview
      • 7.3.3 Merck HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 Merck HEPES Solution Products Offered
      • 7.3.5 Merck Recent Development
    • 7.4 Lonza
      • 7.4.1 Lonza Corporation Information
      • 7.4.2 Lonza Description and Business Overview
      • 7.4.3 Lonza HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Lonza HEPES Solution Products Offered
      • 7.4.5 Lonza Recent Development
    • 7.5 Cytiva
      • 7.5.1 Cytiva Corporation Information
      • 7.5.2 Cytiva Description and Business Overview
      • 7.5.3 Cytiva HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Cytiva HEPES Solution Products Offered
      • 7.5.5 Cytiva Recent Development
    • 7.6 Promega Corporation
      • 7.6.1 Promega Corporation Corporation Information
      • 7.6.2 Promega Corporation Description and Business Overview
      • 7.6.3 Promega Corporation HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Promega Corporation HEPES Solution Products Offered
      • 7.6.5 Promega Corporation Recent Development
    • 7.7 MP Biomedicals
      • 7.7.1 MP Biomedicals Corporation Information
      • 7.7.2 MP Biomedicals Description and Business Overview
      • 7.7.3 MP Biomedicals HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 MP Biomedicals HEPES Solution Products Offered
      • 7.7.5 MP Biomedicals Recent Development
    • 7.8 Spectrum Laboratory
      • 7.8.1 Spectrum Laboratory Corporation Information
      • 7.8.2 Spectrum Laboratory Description and Business Overview
      • 7.8.3 Spectrum Laboratory HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Spectrum Laboratory HEPES Solution Products Offered
      • 7.8.5 Spectrum Laboratory Recent Development
    • 7.9 Biological Industries
      • 7.9.1 Biological Industries Corporation Information
      • 7.9.2 Biological Industries Description and Business Overview
      • 7.9.3 Biological Industries HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Biological Industries HEPES Solution Products Offered
      • 7.9.5 Biological Industries Recent Development
    • 7.10 Cayman Chemical
      • 7.10.1 Cayman Chemical Corporation Information
      • 7.10.2 Cayman Chemical Description and Business Overview
      • 7.10.3 Cayman Chemical HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 Cayman Chemical HEPES Solution Products Offered
      • 7.10.5 Cayman Chemical Recent Development
    • 7.11 SERVA Electrophoresis GmbH
      • 7.11.1 SERVA Electrophoresis GmbH Corporation Information
      • 7.11.2 SERVA Electrophoresis GmbH Description and Business Overview
      • 7.11.3 SERVA Electrophoresis GmbH HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.11.4 SERVA Electrophoresis GmbH HEPES Solution Products Offered
      • 7.11.5 SERVA Electrophoresis GmbH Recent Development
    • 7.12 Bio-Techne
      • 7.12.1 Bio-Techne Corporation Information
      • 7.12.2 Bio-Techne Description and Business Overview
      • 7.12.3 Bio-Techne HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.12.4 Bio-Techne Products Offered
      • 7.12.5 Bio-Techne Recent Development
    • 7.13 BioSpectra
      • 7.13.1 BioSpectra Corporation Information
      • 7.13.2 BioSpectra Description and Business Overview
      • 7.13.3 BioSpectra HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.13.4 BioSpectra Products Offered
      • 7.13.5 BioSpectra Recent Development
    • 7.14 Corning
      • 7.14.1 Corning Corporation Information
      • 7.14.2 Corning Description and Business Overview
      • 7.14.3 Corning HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.14.4 Corning Products Offered
      • 7.14.5 Corning Recent Development
    • 7.15 FUJIFILM Irvine Scientific, Inc.
      • 7.15.1 FUJIFILM Irvine Scientific, Inc. Corporation Information
      • 7.15.2 FUJIFILM Irvine Scientific, Inc. Description and Business Overview
      • 7.15.3 FUJIFILM Irvine Scientific, Inc. HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.15.4 FUJIFILM Irvine Scientific, Inc. Products Offered
      • 7.15.5 FUJIFILM Irvine Scientific, Inc. Recent Development
    • 7.16 Dojindo Laboratories
      • 7.16.1 Dojindo Laboratories Corporation Information
      • 7.16.2 Dojindo Laboratories Description and Business Overview
      • 7.16.3 Dojindo Laboratories HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.16.4 Dojindo Laboratories Products Offered
      • 7.16.5 Dojindo Laboratories Recent Development
    • 7.17 XZL Bio-Technology
      • 7.17.1 XZL Bio-Technology Corporation Information
      • 7.17.2 XZL Bio-Technology Description and Business Overview
      • 7.17.3 XZL Bio-Technology HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.17.4 XZL Bio-Technology Products Offered
      • 7.17.5 XZL Bio-Technology Recent Development
    • 7.18 Suzhou Yacoo Science
      • 7.18.1 Suzhou Yacoo Science Corporation Information
      • 7.18.2 Suzhou Yacoo Science Description and Business Overview
      • 7.18.3 Suzhou Yacoo Science HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.18.4 Suzhou Yacoo Science Products Offered
      • 7.18.5 Suzhou Yacoo Science Recent Development
    • 7.19 Haihang Chemical
      • 7.19.1 Haihang Chemical Corporation Information
      • 7.19.2 Haihang Chemical Description and Business Overview
      • 7.19.3 Haihang Chemical HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.19.4 Haihang Chemical Products Offered
      • 7.19.5 Haihang Chemical Recent Development
    • 7.20 Yunbang Bio-pharmaceutical
      • 7.20.1 Yunbang Bio-pharmaceutical Corporation Information
      • 7.20.2 Yunbang Bio-pharmaceutical Description and Business Overview
      • 7.20.3 Yunbang Bio-pharmaceutical HEPES Solution Sales, Revenue and Gross Margin (2017-2022)
      • 7.20.4 Yunbang Bio-pharmaceutical Products Offered
      • 7.20.5 Yunbang Bio-pharmaceutical Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 HEPES Solution Industry Chain Analysis
    • 8.2 HEPES Solution Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 HEPES Solution Distributors
    • 8.3 HEPES Solution Production Mode & Process
    • 8.4 HEPES Solution Sales and Marketing
      • 8.4.1 HEPES Solution Sales Channels
      • 8.4.2 HEPES Solution Distributors
    • 8.5 HEPES Solution Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:
      Get latest Market Research Reports on HEPES Solution. Industry analysis & Market Report on HEPES Solution is a syndicated market report, published as Global and United States HEPES Solution Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of HEPES Solution market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,850.00
      $7,700.00
      3,033.80
      6,067.60
      3,542.00
      7,084.00
      599,137.00
      1,198,274.00
      321,013.00
      642,026.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report